Global Infectious Diseases Diagnostics Market will Reach US$ 1503.8 Mn by 2024
According to the latest market report published by Persistence Market Research, titled “Global Market Study on Infectious Diseases Diagnostics: Increasing Demand for Evidence-Based Treatment to Boost Demand for Infectious Diagnostic Testing during Forecast Period”. The global market for infectious diseases diagnostics is estimated to reach US$ 876.6 Mn in 2016 from US$ 827.7 Mn in 2015 owing to increasing demand for diagnostic kits caused by rising incidence rate of infectious diseases.
The
global infectious disease diagnostics market is expected to reach US$
1503.8 Mn by 2024. Sexually Transmitted Diseases (STDs) segment is
expected to continue to remain the largest segment by diseases
indication accounting for US$ 282.4 Mn in terms of revenue in 2016, a Y –
o – Y increase of 7.0% over 2015. The chlamydia diagnostics test kits
are expected to gain upward momentum in 2016, growing at 8.9% in terms
of revenue, the fastest among disease indication segment.
Request to view table of content @ https://www.persistencemarketresearch.com/toc/11413
Cell
cultures segment is expected to register highest CAGR in terms of
revenue, by test type accounting for US$ 311.4 Mn in terms of revenue in
2016. The affordability of cell culture kits and large applications in
diagnosis of several infectious diseases is gaining traction.
Consumption demand for cell culture test kits will witness a growth rate
of 7.2 % in 2016 over 2015.
Diagnostic
centers end user segment is expected to register highest CAGR in terms
of revenue, accounting for US$ 392.8 Mn in terms of revenue in 2016. The
increasing number of diagnostics centers, worldwide and a large number
of patient pool depending on diagnostics centers for diagnosis of
infectious diseases is expected to increase demand for diagnostics tests
among diagnostics centers. The diagnostics centers end user segment
will witness a growth rate of 7.4 % in 2016 over 2015.
Request Sample Report@ https://www.persistencemarketresearch.com/samples/11413
Becton,
Dickinson and Company, Cepheid, Inc. Abbott Laboratories, bioMérieux
SA, Hologic, Inc., Danaher Corporation, Thermo Fisher Scientific Inc.,
Roche Diagnostics, Alere Inc., DiaSorin S.p.A., Quidel Corporation, and
Bio-Rad Laboratories, Inc. are key players in the market. Top players
are focusing on developing new products and improving sensitivity and
specificity of the test kits. Collaborations and joint ventures among
manufacturers and local governments are key business strategies being
adopted to increase market share.
PMR
Long-term Outlook: PMR projects the global infectious disease
diagnostics market to witness moderate growth during the forecast period
2016–2024. APAC will continue to remain the largest market for
infectious disease diagnostics, registering a CAGR of 7.9% over the
forecast period
Comments
Post a Comment